Frankfurt - Delayed Quote EUR

Scancell Holdings plc (SCP.F)

0.0950
-0.0010
(-1.04%)
At close: 9:07:01 AM GMT+2
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Revenue
0
0
5,271
0
0
Cost of Revenue
0
0
525
0
--
Gross Profit
0
0
4,746
0
--
Operating Expense
18,267
18,267
16,666
13,299
8,834
Operating Income
-18,267
-18,267
-11,920
-13,299
-8,834
Net Non Operating Interest Income Expense
-734
-734
-931
-1,773
-7,971
Pretax Income
-9,117
-9,117
-14,304
-6,272
-16,805
Tax Provision
-3,258
-3,258
-2,368
-1,703
-1,328
Net Income Common Stockholders
-5,859
-5,859
-11,936
-4,569
-15,477
Average Dilution Earnings
-8,853
-8,853
0
--
--
Diluted NI Available to Com Stockholders
-14,712
-14,712
-11,936
-4,569
-15,477
Basic EPS
-0.01
-0.01
-0.01
-0.00
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.00
-0.02
Basic Average Shares
818,271.6040
862,484.4300
816,051.3110
815,535.4200
678,892.3250
Diluted Average Shares
819,981.7760
1,029,794.4650
816,051.3110
815,535.4200
678,892.3250
Total Operating Income as Reported
-18,267
-18,267
-11,920
-13,299
-8,834
Rent Expense Supplemental
123
--
--
--
--
Total Expenses
18,267
18,267
17,191
13,299
8,834
Net Income from Continuing & Discontinued Operation
-5,859
-5,859
-11,936
-4,569
-15,477
Normalized Income
-12,210.9092
-12,210.9092
-10,723.5414
-10,979.5867
-15,477
Interest Income
355
355
284
4
3
Interest Expense
1,089
1,089
1,215
1,777
1,651
Net Interest Income
-734
-734
-931
-1,773
-7,971
EBIT
-8,028
-8,028
-13,089
-4,495
-15,154
EBITDA
-7,062
-7,062
-12,187
-3,755
-14,905
Reconciled Cost of Revenue
0
0
525
0
--
Reconciled Depreciation
966
966
902
740
249
Net Income from Continuing Operation Net Minority Interest
-5,859
-5,859
-11,936
-4,569
-15,477
Total Unusual Items Excluding Goodwill
9,884
9,884
-1,453
8,800
0
Total Unusual Items
9,884
9,884
-1,453
8,800
0
Normalized EBITDA
-16,946
-16,946
-10,734
-12,555
-14,905
Tax Rate for Calcs
0.0004
0.0004
0.0002
0.0003
0.0001
Tax Effect of Unusual Items
3,532.0908
3,532.0908
-240.5414
2,389.4133
0
4/30/2021 - 8/19/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

22Z.SG Zealand Pharma A/S
59.96
-0.40%
 
BT3.BE Lineage Cell Therapeutics Inc
0.3840
+2.67%
 
328.SG MeiraGTx Holdings PLC
4.8000
+0.42%
 
25I.SG ImmuPharma PLC
0.0295
-1.67%
 
6XC.F Soleno Therapeutics, Inc.
64.05
+2.89%
 
XUPB.F Genfit S.A.
3.8000
-1.04%
 
GNFTF Genfit S.A.
3.5400
0.00%
 
AYJ.HA Valneva SE
2.8500
-1.99%
 
PI3.DU Gubra AS
51.00
-1.26%
 
2L9.SG Blueprint Medicines Corp
88.12
+1.66%